Azitra (AZTR) Preferred Dividend Payments (2022 - 2023)
Azitra (AZTR) reported Preferred Dividend Payments of $643267.0 for Q2 2023, down 7.08% on a YoY basis from $692246.0 in Q2 2022, and down 9.66% quarter-over-quarter from $712080.0 in Q1 2023.
Azitra (AZTR) Preferred Dividend Payments (2022 - 2023) Analysis & Trends
Azitra has reported Preferred Dividend Payments for 2 years, with the latest figure at $643267.0 in Q2 2023.
- For the quarter ending Q2 2023, Preferred Dividend Payments fell 7.08% year-over-year to $643267.0; the trailing twelve-month figure through Mar 2024 stood at $643267.0 (down 76.93% YoY), and the FY2023 full-year result was $1.4 million, down 51.05% from the prior year.
- Preferred Dividend Payments for Q2 2023 stood at $643267.0, down from $712080.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $712080.0 in Q1 2023, with the low at $643267.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 643,267.00 |
| Mar 31, 2023 | 712,080.00 |
| Dec 31, 2022 | 692,247.00 |
| Sep 30, 2022 | 692,246.00 |
| Jun 30, 2022 | 692,246.00 |